Deputy Scientific Director of IEPT CEM SAS, the member of the Department of tissue cultures and biochemical engineering
Ing. Zuzana Brnoliaková, PhD.
National
Finished
- The use of mass spectrometry for comparative study of different rats strains glycoprofiles within metabolic disturbances interventionProgram: VEGADuration: 1. 1. 2021 – 31. 12. 2023
- Innovative approaches in toxicology of ageingProgram: SRDADuration: 1. 7. 2019 – 30. 6. 2023
- The study of structural changes of complex glycoconjugates in the proces of inherited metabolic and civilization diseasesProgram:Duration: 1. 3. 2021 – 30. 6. 2023
- Effect of fructose diet in experimental models of metabolic syndrome and in healthy subjects: proposal of effective pharmacological treatmentProgram: VEGADuration: 1. 1. 2019 – 31. 12. 2022
- Risk factors of cardiovascular and cerebrovascular diseases and pharmacological possibilities of their influenceProgram: VEGADuration: 1. 1. 2015 – 31. 12. 2018
- Centre of excellence for glycomicsProgram: EU Structural Funds Research & DevelopmentDuration: 1. 10. 2010 – 31. 10. 2013
- Could the diabetic cataract prevention be achieved by substituted pyridoindoles with their antioxidant and aldose reductase inhibitory potential? Study on in vitro cultivated eye lenses from ratsProgram: VEGADuration: 1. 1. 2009 – 31. 12. 2011
- Substituted pyridoindoles as antioxidants and aldose reductase inhibitors in multitarget treatment of diabetic complications: a preclinical studyProgram: VEGADuration: 1. 1. 2008 – 31. 12. 2010
- Developmental Origin of Metabolic Syndrome:Hypertension, Diabetes and DyslipidemiaProgram: VEGADuration: 1. 1. 2008 – 31. 12. 2010
- Ischaemia and reperfusion in experimental diabetes type 2 and possibilities of pharmacological managementProgram: VEGADuration: 1. 1. 2005 – 1. 12. 2007
- Carboxymethylated pyridoindoles as inhibitors of aldose reductase with antioxidant activity: preclinical implicators for pharmacological prevention of diabetic complicationsProgram: VEGADuration: 1. 1. 2005 – 1. 12. 2007